ORIGINAL
PAPER
A Mixed-Method Approach to Evaluate a Pharmacist Intervention for Veterans With Hypertension Christopher P. Parker, PharmD, BCACP;1 Cassie L. Cunningham, MPH;2 Barry L. Carter, PharmD;1,2,3 Mark W. Vander Weg, PhD;2,4,5 Kelly K. Richardson, PhD;2 Gary E. Rosenthal, MD2,4,6 From the Department of Pharmacy Practice and Science, College of Pharmacy, Iowa City, IA;1 Center for Comprehensive Access & Delivery Research and Evaluation, Iowa City VA Health Care System, Iowa City, IA;2 Department of Family Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA;3 Department of Internal Medicine, Division of General Internal Medicine, Carver College of Medicine, Iowa City, IA;4 Department of Psychology, University of Iowa, Iowa City, IA;5 and University of Iowa Institute for Clinical and Translational Science, Iowa City, IA6
This paper examines blood pressure (BP) control after 6 months of an intensive pharmacist-managed intervention in a mixed-methods randomized controlled trial conducted at the Iowa City Veteran Affairs Health Care System and two community-based outreach clinics. Patients received the pharmacist intervention for the first 6 months. The study coordinator conducted a summative evaluation with 37 patients 18 to 24 months following the initial 6-month intervention period. BP was significantly reduced in diabetic patients following an intensive pharmacist intervention
( 8.0/ 4.014.4/9.1 mm Hg systolic/diastolic, P114 mm Hg); (3) a history of acute MI, stroke, or unstable angina in the prior 6 months; (4) congestive heart failure (CHF) caused by systolic dysfunction with a left ventricular ejection fraction 2 times control or total bilirubin > 1.5 mg/dL) in the prior 6 months; (7) pregnancy; (8) prior diagnoses of pulmonary hypertension or sleep apnea (unless treated by continuous positive pressure ventilation); (9) poor prognosis, with a life expectancy estimated to be 200 mm Hg or 114 mm Hg or
PAPER
A Mixed-Method Approach to Evaluate a Pharmacist Intervention for Veterans With Hypertension Christopher P. Parker, PharmD, BCACP;1 Cassie L. Cunningham, MPH;2 Barry L. Carter, PharmD;1,2,3 Mark W. Vander Weg, PhD;2,4,5 Kelly K. Richardson, PhD;2 Gary E. Rosenthal, MD2,4,6 From the Department of Pharmacy Practice and Science, College of Pharmacy, Iowa City, IA;1 Center for Comprehensive Access & Delivery Research and Evaluation, Iowa City VA Health Care System, Iowa City, IA;2 Department of Family Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA;3 Department of Internal Medicine, Division of General Internal Medicine, Carver College of Medicine, Iowa City, IA;4 Department of Psychology, University of Iowa, Iowa City, IA;5 and University of Iowa Institute for Clinical and Translational Science, Iowa City, IA6
This paper examines blood pressure (BP) control after 6 months of an intensive pharmacist-managed intervention in a mixed-methods randomized controlled trial conducted at the Iowa City Veteran Affairs Health Care System and two community-based outreach clinics. Patients received the pharmacist intervention for the first 6 months. The study coordinator conducted a summative evaluation with 37 patients 18 to 24 months following the initial 6-month intervention period. BP was significantly reduced in diabetic patients following an intensive pharmacist intervention
( 8.0/ 4.014.4/9.1 mm Hg systolic/diastolic, P114 mm Hg); (3) a history of acute MI, stroke, or unstable angina in the prior 6 months; (4) congestive heart failure (CHF) caused by systolic dysfunction with a left ventricular ejection fraction 2 times control or total bilirubin > 1.5 mg/dL) in the prior 6 months; (7) pregnancy; (8) prior diagnoses of pulmonary hypertension or sleep apnea (unless treated by continuous positive pressure ventilation); (9) poor prognosis, with a life expectancy estimated to be 200 mm Hg or 114 mm Hg or
